Nintedanib

Nintedanib

NINTEDONE 150 is approved for the treatment of idiopathic pulmonary fibrosis, a progressive lung disease characterized by the scarring of lung tissue, which leads to reduced lung function and breathing difficulties.It is also approved for the treatment of systemic sclerosis-associated interstitial lung disease, a complication of systemic sclerosis (scleroderma) that affects the lungs. NINTEDONE 150  is classified as a tyrosine kinase inhibitor. It works by blocking certain growth factors and signaling pathways that are involved in the fibrotic process in the lungs. By doing so, it can slow down the progression of fibrosis and preserve lung function.Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
info@sterispharma.com
order now:https://www.sterisonline.com/product/nintedone-150-133671